Cornuside ameliorates cognitive impairments in scopolamine induced AD mice: Involvement of neurotransmitter and oxidative stress
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cornuside ameliorates cognitive impairments in scopolamine induced AD mice: Involvement of neurotransmitter and oxidative stress
Authors
Keywords
-
Journal
JOURNAL OF ETHNOPHARMACOLOGY
Volume 293, Issue -, Pages 115252
Publisher
Elsevier BV
Online
2022-04-09
DOI
10.1016/j.jep.2022.115252
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Urtica dioica extracts abolish scopolamine-induced neuropathies in rats
- (2021) Ali H. Abu Almaaty et al. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
- Role of natural products for the treatment of Alzheimer's disease
- (2021) Tayebeh Noori et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cornel Iridoid Glycoside Suppresses Tau Hyperphosphorylation and Aggregation in a Mouse Model of Tauopathy through Increasing Activity of PP2A
- (2020) Denglei Ma et al. Current Alzheimer Research
- Potentiation of anti-Alzheimer activity of curcumin by probiotic Lactobacillus rhamnosus UBLR-58 against scopolamine-induced memory impairment in mice
- (2020) Chirag Patel et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- GAPT regulates cholinergic dysfunction and oxidative stress in the brains of learning and memory impairment mice induced by scopolamine
- (2020) Zhenhong Liu et al. Brain and Behavior
- [6]-Gingerol Ameliorates Cisplatin-Induced Pica by Regulating the TPH/MAO-A/SERT/5-HT/5-HT3 Receptor System in Rats
- (2020) Qianqian Cheng et al. Drug Design Development and Therapy
- GPR68 deletion impairs hippocampal long-term potentiation and passive avoidance behavior
- (2020) Yuanyuan Xu et al. Molecular Brain
- Association Between Oxidative Stress and Altered Cholesterol Metabolism in Alzheimer’s Disease Patients
- (2020) Amira Zarrouk et al. Current Alzheimer Research
- Treatment of Alzheimer’s Disease: Trazodone, Sleep, Serotonin, Norepinephrine, and Future Directions
- (2019) John Wesson Ashford JOURNAL OF ALZHEIMERS DISEASE
- Elaeagnus glabra f. oxyphylla Attenuates Scopolamine-Induced Learning and Memory Impairments in Mice by Improving Cholinergic Transmission via Activation of CREB/NGF Signaling
- (2019) Sohn et al. Nutrients
- Loganin Exerts Sedative and Hypnotic Effects via Modulation of the Serotonergic System and GABAergic Neurons
- (2019) Rui Shi et al. Frontiers in Pharmacology
- Serotonergic system, cognition, and BPSD in Alzheimer’s disease
- (2019) Saikat Chakraborty et al. NEUROSCIENCE LETTERS
- Dopamine and Dopamine Receptors in Alzheimer's Disease: A Systematic Review and Network Meta-Analysis
- (2019) Xiongfeng Pan et al. Frontiers in Aging Neuroscience
- MDGA1-deficiency attenuates prepulse inhibition with alterations of dopamine and serotonin metabolism: An ex vivo HPLC-ECD analysis
- (2019) Md Razib Hossain et al. NEUROSCIENCE LETTERS
- Schisandrin ameliorates cognitive impairment and attenuates Aβ deposition in APP/PS1 transgenic mice: involvement of adjusting neurotransmitters and their metabolite changes in the brain
- (2018) Bin-bin Wei et al. ACTA PHARMACOLOGICA SINICA
- The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
- (2018) Harald Hampel et al. BRAIN
- Network Medicine for Alzheimer’s Disease and Traditional Chinese Medicine
- (2018) Juliet Jarrell et al. MOLECULES
- Targeted Neurotransmitters Profiling Identifies Metabolic Signatures in Rat Brain by LC-MS/MS: Application in Insomnia, Depression and Alzheimer’s Disease
- (2018) Huarong Xu et al. MOLECULES
- The Early Events That Initiate β-Amyloid Aggregation in Alzheimer’s Disease
- (2018) Xingyu Zhang et al. Frontiers in Aging Neuroscience
- Genistein Ameliorates Scopolamine-Induced Amnesia in Mice Through the Regulation of the Cholinergic Neurotransmission, Antioxidant System and the ERK/CREB/BDNF Signaling
- (2018) Cong Lu et al. Frontiers in Pharmacology
- Therapeutics of Neurotransmitters in Alzheimer’s Disease
- (2017) Ramesh Kandimalla et al. JOURNAL OF ALZHEIMERS DISEASE
- Cornusides A–O, Bioactive Iridoid Glucoside Dimers from the Fruit of Cornus officinalis
- (2017) Xian-Sheng Ye et al. JOURNAL OF NATURAL PRODUCTS
- The cholinergic anti-inflammatory pathway: An innovative treatment strategy for neurological diseases
- (2017) Bin Han et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- On the path to 2025: understanding the Alzheimer’s disease continuum
- (2017) Paul S. Aisen et al. Alzheimers Research & Therapy
- Alzheimer’s disease: experimental models and reality
- (2016) Eleanor Drummond et al. ACTA NEUROPATHOLOGICA
- Systemic lipopolysaccharide-mediated alteration of cortical neuromodulation involves increases in monoamine oxidase-A and acetylcholinesterase activity
- (2015) Zhi Ming et al. Journal of Neuroinflammation
- Status of Acetylcholinesterase and Butyrylcholinesterase in Alzheimer's Disease and Type 2 Diabetes Mellitus
- (2014) Gohar Mushtaq et al. CNS & Neurological Disorders-Drug Targets
- Tetrandrine, an antihypertensive alkaloid, improves the sleep state of spontaneously hypertensive rats (SHRs)
- (2013) Juan Zhang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness
- (2006) Moussa B H Youdim et al. BRITISH JOURNAL OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started